Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7086931 Inquire
Recombinant Mouse Olfactory receptor 146 (Olfr146), partial
Sign In for Pricing
View Details 
MBS1459362-01 0.02 mg (E-Coli)
Recombinant Clostridium perfringens UPF0473 protein CPE1777 (CPE1777)
Sign In for Pricing
View Details 
MBS1459362-02 0.1 mg (E-Coli)
Recombinant Clostridium perfringens UPF0473 protein CPE1777 (CPE1777)
Sign In for Pricing
View Details MBS1459362-03 0.02 mg (Yeast)
Recombinant Clostridium perfringens UPF0473 protein CPE1777 (CPE1777)
Sign In for Pricing
View Details 
MBS1459362-04 0.1 mg (Yeast)
Recombinant Clostridium perfringens UPF0473 protein CPE1777 (CPE1777)
Sign In for Pricing
View Details MBS1459362-05 0.02 mg (Baculovirus)
Recombinant Clostridium perfringens UPF0473 protein CPE1777 (CPE1777)
Sign In for Pricing
View Details